Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: CON, PDT

Adapty Delivers First Ever Insite Online B2B Commerce Implementation for a Leading Distributor of Process Equipment

NEW JERSEY CITY, NEW JERSEY, June 3, 2020 /PRNewswire/ -- Adapty Inc., a leading digital commerce and customer experience company, today announced the successful roll-out of a B2B e-commerce solution for Carotek, USA. Adapty partnered with Insite, an Episerver company, and Digital DNA Marketing agency to implement InsiteOnline, an out-of-the-box commerce solution, for the process equipment distribution business of Carotek.

The shift to digital was imperative in the B2B (business to business) space and particularly now in the economic crisis caused by Covid19 pandemic it has gained more significance. Digital transformation in traditional manufacturing and distribution business has the potential to completely change how clients interact with brands and run their businesses.

Carotek a leading distributor of process equipment in the USA, partnered with Adapty to implement a responsive B2B platform. As part of the implementation, the corporate site and e-commerce portal were merged to give the customer a single site view thereby improving the user experience. The implementation delivered improved customer experience and reduced customer service dependency. This is the first ever InsiteOnline platform implementation for B2B business.

Comments on the News:

"Adapty implemented our new InsiteOnline website for Carotek.com. Because this was a new platform, the challenges were higher than normal. Adapty was extremely diligent at problem solving, and very thorough in the QA process. They were willing to go the extra mile to get things done correctly. They were patient with the learning necessary to complete implementation and very supportive during launch." - Carotek

Adapty besides having solid B2C e-commerce capability also specializes in providing B2B digital commerce solutions for manufacturing and distribution businesses worldwide.

About Insite, an Episerver company

A company that holds powerful experience in designing a world-class e-commerce platform, to handle solutions for companies at all stages of adoption and addresses the unique needs of B2B and B2C sites. Named a Leader in B2B e-commerce in The Forrester Wavetm: B2B Commerce Suites, Q3, 2018. For more information visit www.insitesoft.com

About Adapty

Adapty is a leading digital commerce company with offices in USA, UAE and India. Adapty specializes in B2C, B2B, and B2B2C ecommerce solutions. As experts in digital commerce and customer experience platforms, our technology teams design and implement omnichannel solutions that drive customer engagement and enable business growth. For more information visit www.adapty.com

Vinay Rane

Logo - https://mma.prnewswire.com/media/1175919/Adapty_Logo.jpg  
Photo - https://mma.prnewswire.com/media/1175920/Adapty_insite.jpg

These press releases may also interest you

at 07:45
Tecsys Inc. , an industry-leading supply chain management software company, jumps 37% year-over-year to post its first $100 million-plus fiscal year revenue performance for 2020. The company heads...

at 07:45
Media Stream is excited to announce its new partnership with The Holistic Chamber of Commerce (HCC) to offer members significant discounts on website development packages. Additionally, in light of the hardships created by the COVID-19 pandemic,...

at 07:40
ZYUS Life Sciences Inc. ("ZYUS"), a company dedicated to improving quality of life through research and leadership in bio-pharmaceuticals and cannabinoid-based formulations, announced today that it has reached a positive milestone in the development...

at 07:36
The Palais des congrès de Montréal is continuing to proactively respond to the challenges the events industry is facing by innovatively adapting its services and solutions. Today, it unveils its latest strategic initiative aimed at shaping the...

at 07:35
AstraZeneca today announced that Survivors Have Heart, a national community-building movement powered by stories of heart attack survivors and their loved ones, will return for its third year. This year, through a series of virtual meetings and live...

at 07:35
Novocure today announced it has entered into a clinical trial collaboration agreement with MSD (a tradename of Merck & Co., Inc.), through a subsidiary, to develop Tumor Treating Fields together with MSD's anti-PD-1 therapy KEYTRUDA® (pembrolizumab)...

News published on 3 june 2020 at 01:00 and distributed by: